Kari Stefansson News
-
Amgen Inc., the world’s largest biotechnology company, agreed to buy the genetic-research company DeCode Genetics Inc. for $415 million to help it develop new medicines that target defective DNA.
-
A newly discovered gene variant may point to another route Alzheimer’s disease takes to ravage the brain: through the immune system.
-
The discovery of a rare genetic mutation that prevents formation of brain plaques associated with Alzheimer’s disease may be proof that the idea behind a new class of drugs in development is valid, scientists said.
-
In separate probes into the roots of Alzheimer’s, scientists have uncovered a rare gene mutation that keeps plaque from forming in the brain and found the disease may take hold 25 years before symptoms appear.
-
Personal gene-testing is coming to a Walgreen’s near you and may, in the process, be setting off a battle with U.S. regulators.
-
Children of older fathers are known to be more at risk for diseases including schizophrenia and autism. Now, a new scientific look at the genes passed down within families may have pinpointed a reason why.
-
A gene scan that identifies an individual man’s DNA variants improves the predictive power of the test commonly used to gauge the risk of prostate cancer, a study from DeCode Genetics Inc. found.
-
Gene testing companies such as 23andMe Inc . and DeCode Genetics Inc. should be regulated because consumers may make wrong medical decisions based on inaccurate or misinterpreted results, scientists said.
-
Personal genetic tests now being sold by five companies require government review, U.S. regulators said, one month after Walgreen Co. scrapped plans to sell a similar product in its stores.
-
Four gene-testing companies are misleading U.S. consumers by providing unclear or conflicting information on the risk of disease, according to a government investigator who sampled the services on the Internet.
|
|
Most Popular on Bloomberg
|
| |
Rate this Page